CanSino Biologics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	2,023	2,822	3,465	5,645
Short-Term Investments	-	-	-	-	275.2
Trading Asset Securities	-	1,182	1,308	2,482	1,862
Cash & Short-Term Investments	2,791	3,204	4,130	5,947	7,783
Cash Growth	-12.90%	-22.41%	-30.55%	-23.59%	52.19%
Accounts Receivable	-	737.62	636.88	855.49	157.93
Other Receivables	-	81.11	3.98	0.54	19.15
Receivables	-	818.73	640.87	856.03	177.08
Inventory	-	283.41	352.85	677.78	875.62
Prepaid Expenses	-	-	0.25	-	-
Other Current Assets	-	-24.03	57	249.59	454.49
Total Current Assets	-	4,282	5,181	7,730	9,290
Property, Plant & Equipment	-	2,641	3,013	3,069	2,218
Long-Term Investments	-	483.71	446.56	50.12	45.31
Other Intangible Assets	-	115.49	144.15	220.92	172.12
Long-Term Deferred Tax Assets	-	205.39	207.86	196.41	-
Long-Term Deferred Charges	-	172.21	88.4	51.95	26.19
Other Long-Term Assets	-	57.99	237.53	150.37	122.42
Total Assets	-	7,958	9,319	11,469	11,874
Accounts Payable	-	62.47	103.97	253.12	842.57
Accrued Expenses	-	401.46	454.55	407.25	362.44
Short-Term Debt	-	377.35	883.97	1,530	990.68
Current Portion of Long-Term Debt	-	513.44	509.17	45.77	90.11
Current Portion of Leases	-	9.99	64.63	48.76	31.18
Current Income Taxes Payable	-	4.66	0.54	3	29.14
Current Unearned Revenue	-	14.69	3.57	1.48	193.22
Other Current Liabilities	-	302.68	544.9	635.52	322.08
Total Current Liabilities	-	1,687	2,565	2,925	2,861
Long-Term Debt	-	1,099	1,066	878.01	40
Long-Term Leases	-	12.68	175.18	198.29	222.85
Long-Term Unearned Revenue	-	250.3	216.72	222.35	201.48
Long-Term Deferred Tax Liabilities	-	-	-	-	0.56
Other Long-Term Liabilities	-	-	8.49	-	-
Total Liabilities	-	3,048	4,031	4,223	3,326
Common Stock	-	247.45	247.45	247.45	247.45
Additional Paid-In Capital	-	6,577	6,574	6,608	6,598
Retained Earnings	-	-1,819	-1,440	42.71	1,150
Treasury Stock	-	-95.62	-106.17	-150.17	-
Comprehensive Income & Other	-	0.22	-0.18	0.12	-
Total Common Equity	4,931	4,910	5,275	6,748	7,995
Minority Interest	-	-	12.81	497.51	552.84
Shareholders' Equity	4,931	4,910	5,287	7,246	8,548
Total Liabilities & Equity	-	7,958	9,319	11,469	11,874
Total Debt	1,425	2,012	2,699	2,701	1,375
Net Cash (Debt)	1,366	1,192	1,431	3,246	6,408
Net Cash Growth	14.54%	-16.69%	-55.91%	-49.34%	28.90%
Net Cash Per Share	5.39	4.82	5.80	13.14	25.91
Filing Date Shares Outstanding	291.55	249.18	247.04	246.77	247.45
Total Common Shares Outstanding	291.55	249.18	247.04	246.77	247.45
Working Capital	-	2,596	2,616	4,805	6,428
Book Value Per Share	27.01	19.70	21.35	27.35	32.31
Tangible Book Value	4,739	4,794	5,130	6,527	7,823
Tangible Book Value Per Share	25.95	19.24	20.77	26.45	31.61
Buildings	-	1,025	978.89	729.03	724.68
Machinery	-	773.61	1,189	1,050	537.75
Construction In Progress	-	1,268	1,114	1,342	820.8

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.